New methods to approach immunotherapy of cancer - And strategies of tumours to avoid elimination: Conference report, on behalf of EUCAPS

Cancer Immunology Immunotherapy

Volumn 49, Issue 4-5, 2000, Pages 276-280

  Pawelec, Graham ^a  

^a UNIVERSITY OF TÜBINGEN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 2;

ADOPTIVE IMMUNOTHERAPY; ANTIGEN EXPRESSION; CANCER IMMUNOLOGY; CANCER IMMUNOTHERAPY; CANCER INHIBITION; CONFERENCE PAPER; HUMAN; IMMUNOMODULATION; IMMUNOSURVEILLANCE; NONHUMAN; PRIORITY JOURNAL; TUMOR ESCAPE;

EID: 0033915396     PISSN: 03407004     EISSN: None     Source Type: Journal    
DOI: 10.1007/s002620000119     Document Type: Conference Paper

References (2)

1. Pawelec G (1999) Tumour escape from the immune response: the last hurdle for successful immunotherapy of cancer? Introduction to Symposium in Writing. Tumour escape from the immune response. Cancer Immunol Immunother 48: 343
2. Pawelec G, Engel A, Adibzadeh M (1999) Prerequisites for the immunotherapy of cancer. Cancer Immunol Immunother 48: 214